Newsletter Signup | Join Community
Avelumab Immunotherapy Approved for Bladder Cancer
Treatment of non-muscle invasive bladder cancers continues to improve with the use of immunotherpay.
Cancer Connect - Stage IV Bladder Cancer
Information on Recurrent Bladder Cancer
FDA approves Padcev - a novel antibody drug conjugate precision medicine for treatment of advanced bladder cancer.
FDA Grants N-803 Combo Breakthrough Therapy Status for Non-Muscle Invasive Bladder Cancer
The checkpoint inhibitor Tecentiq (atezolizumab) improves the outcomes of treatment for bladder cancer.
Can anyone share the experience with Keytruda? Any side effects?